Takeda, Zedira and Dr Falk Pharma ink pact to develop Celiac Disease therapy Ruchika Sharma24 Oct 2022 1:00 PM ISTTAK-227 is a selective, oral small molecule designed to inhibit tissue transglutaminase (TG2), an enzyme that generates immunogenic gluten peptide...
New drug may reduce gluten-induced duodenal mucosal damage in celiac disease: NEJM Dr Satabdi Saha9 July 2021 9:00 AM ISTA new experimental drug may help reduce gluten-induced duodenal mucosal damage in celiac disease, finds a study published in NEJM
